Jeffrey J. Scherman - 06 Mar 2024 Form 4 Insider Report for NeueHealth, Inc. (NEUE)

Role
Chief Accounting Officer
Signature
/s/ Eric Halverson for Jeffrey J. Scherman, Attorney-in-Fact
Issuer symbol
NEUE
Transactions as of
06 Mar 2024
Net transactions value
$0
Form type
4
Filing time
08 Mar 2024, 20:01:10 UTC
Previous filing
11 May 2023
Next filing
11 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEUE Common Stock Options Exercise +2,491 +3.1% 81,911 06 Mar 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NEUE Restricted Stock Units Options Exercise $0 -2,491 -33% $0.000000 4,981 06 Mar 2024 Common Stock 2,491 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F2 These restricted stock units vest in three equal annual installments beginning on March 6, 2024.